80-kV hepatic CT to reduce contrast medium dose in azotemic patients: a feasibility study.

Acta Radiol

Institute of Clinical Sciences, Department of Radiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Published: April 2020

Download full-text PDF

Source
http://dx.doi.org/10.1177/0284185119866807DOI Listing

Publication Analysis

Top Keywords

80-kv hepatic
4
hepatic reduce
4
reduce contrast
4
contrast medium
4
medium dose
4
dose azotemic
4
azotemic patients
4
patients feasibility
4
feasibility study
4
80-kv
1

Similar Publications

Article Synopsis
  • Deep learning-based spectral CT imaging (DL-SCTI) enhances image quality by using advanced networks to fill in missing data and improve visual accuracy for dual-energy scans.
  • A clinical study involving 52 patients with hypervascular hepatocellular carcinoma (HCC) found that DL-SCTI-generated iodine maps significantly improved the contrast-to-noise ratio (CNR) during the hepatic arterial phase compared to standard 70 keV images.
  • While DL-SCTI effectively detects HCCs, it may underestimate iodine concentration in small lesions or lower concentrations, indicating limitations in certain scenarios.
View Article and Find Full Text PDF

Background: Blending technology is usually used to improve quality of dual-energy computed (DECT) images.

Objectives: To evaluate the blended DECT image qualities by employing the Blending-Property-Map (BP-Map) and elucidating the optimal parameters with the highest signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR).

Methods: Sixty pairs of 80 kV and 140 kV CT images are blended non-linearly by four methods.

View Article and Find Full Text PDF

Objectives: To evaluate multiphase low kV computed tomography (CT) imaging of the abdomen with reduced contrast media (CM) dose using different injection protocols.

Methods: Two injection protocols were evaluated for use with low kV (80 kV) multiphase abdominal imaging in comparison to the standard procedure acquired at 120 kV (500 mgI/kg; 5 mL/s). This evaluation was conducted in a highly standardized animal study (5 Goettingen minipigs).

View Article and Find Full Text PDF
Article Synopsis
  • The study examines how a decreased injection flow rate of a contrast agent affects aortic enhancement, both through a controlled lab experiment and in a clinical setting.
  • In the phantom experiment, a lower flow rate resulted in a slight reduction (6%-9%) in simulated aortic peak enhancement.
  • The clinical study found that age was the only significant factor influencing aortic enhancement, while the reduced flow rate didn’t significantly impact aortic enhancement during actual CT scans.
View Article and Find Full Text PDF

Aim: To compare the diagnostic value of liver perfusion computed tomography (PCT) and biphasic contrast-enhanced CT (bpCECT) for detection and characterization of hepatocellular carcinoma (HCC), and to identify potential causes for inter-modal discrepancies.

Patients And Methods: In this retrospective study, 162 cases with a total of 325 HCC-typical lesions were evaluated using both PCT and bpCECT (mean time between examinations=15 days, range=0-13 days). HCC diagnosis was performed by multi-modality imaging including lesion growth at follow-up.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!